Victor P.
- Country
- France
- Department
- Hémato-onco-pédiatrie
Research Overview
Data & Insights
Has run more than one trial at 0 of 105 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating childhood and adolescent lymphomas, with particular emphasis on ALK-positive anaplastic large cell lymphoma (ALCL). Their research focuses on developing targeted therapeutic approaches for pediatric cancer patients.
- Standard risk ALCL management
- Pediatric lymphoma treatment protocols
- Long-term therapeutic strategies
The investigator explores innovative treatment approaches using Vinblastine-based therapies in pediatric oncology settings.
Targeted Therapies
Their work centers on investigating monotherapy treatment approaches in pediatric cancer care, particularly focusing on optimizing treatment duration and efficacy for young patients with lymphoid malignancies.
- Extended duration treatments
- Risk-stratified approaches
- Treatment optimization strategies
The investigator evaluates therapeutic outcomes in standard risk lymphoma cases, working to establish effective treatment protocols.
Clinical Applications
Their clinical interests encompass the development of therapeutic protocols for ALK-positive lymphomas, with a focus on determining optimal treatment durations and monitoring patient responses.
- Response assessment methods
- Treatment duration optimization
- Patient outcome monitoring
The investigator's work aims to enhance treatment efficacy in pediatric lymphoma care through systematic therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.